background
influenza
antigen
pointofcar
poc
test
insensit
individu
reliabl
diagnosi
influenza
viru
infect
without
addit
laboratori
confirm
molecular
poc
test
could
valuabl
altern
object
evalu
first
influenza
molecular
poc
test
commerci
avail
cepheid
xpert
flu
panel
design
simultan
detect
influenza
viru
subtyp
pandem
viru
compar
inhous
realtim
rtpcr
qrtpcr
studi
design
clinic
specimen
posit
influenza
viru
influenza
viru
isol
differ
viral
load
differ
type
subtyp
use
determin
analyt
reactiv
sensit
panel
pathogen
neg
specimen
isol
differ
respiratori
pathogen
use
determin
analyt
specif
sensit
similar
qrtpcr
rang
viral
particl
per
ml
howev
subtyp
specimen
cycl
threshold
valu
greater
qrtpcr
specimen
inconsist
result
qrtpcr
due
primer
probe
mismatch
detect
xpert
flu
panel
analyt
specif
conclus
xpert
flu
panel
first
commerci
avail
poc
molecular
test
detect
influenza
viru
determin
subtyp
analyt
reason
sensit
compar
qrtpcr
highli
specif
therefor
welcom
altern
antigen
poc
test
diagnosi
influenza
viru
infect
varieti
techniqu
use
applic
depend
clinic
set
purpos
time
consum
viru
isol
requir
determin
antigen
match
influenza
vaccin
whilst
pointofcar
poc
antigen
test
use
rapid
determin
infect
abl
time
implement
therapi
patient
prevent
measur
limit
spread
outbreak
situat
major
drawback
howev
poc
antigen
test
rel
insensit
henc
unsuit
individu
patient
diagnosi
without
addit
confirmatori
test
therefor
need
sensit
poc
test
aros
particular
diagnos
infect
highli
fatal
influenza
viru
although
realtim
rtpcr
qrtpcr
rapid
need
expens
equip
well
suit
laboratori
train
personnel
rna
purif
rtpcr
reagent
prepar
still
take
hour
main
bottleneck
develop
poc
qrtpcr
sampl
prepar
combin
sampl
prepar
singl
multiplex
qrtpcr
close
system
assay
complet
within
hour
pandem
viru
includ
assay
poc
qrtpcr
system
could
particular
use
onsit
triag
rapid
easi
diagnosi
offoffic
hour
first
commerci
avail
poc
qrt
evalu
xpert
flu
panel
poc
test
comparison
inhous
realtim
rtpcr
qrtpcr
assay
use
influenza
viru
detect
subtyp
pandem
viru
primer
en
probe
xpert
flu
panel
design
gener
detect
type
influenza
viru
matrix
gene
specif
detect
haemagglutinin
gene
pandem
viru
panel
consist
singleus
cartridg
freezedri
reagent
rna
extract
realtim
rtpcr
nucleic
acid
bind
reagent
squeez
ampoul
specimen
use
dispos
pipett
provid
kit
ad
genexpert
dx
system
cepheid
sunnyv
ca
attach
laptop
comput
barcod
reader
use
assay
perform
accord
manufactur
instruct
briefli
nucleic
acid
purifi
specimen
use
magnapur
lc
system
magnapur
lc
total
nucleic
acid
isol
kit
roch
diagnost
almer
netherland
qrtpcr
perform
lightcycl
roch
diagnost
primari
qrtpcr
diagnost
clinic
specimen
initi
done
use
taqman
master
kit
twostep
qrtpcr
roch
diagnost
almer
netherland
replac
pandem
taqman
ez
rtpcr
core
reagent
kit
onestep
qrtpcr
appli
biosystem
nieuwerkerk
aan
den
ijssel
netherland
optim
comparison
influenza
viru
contain
specimen
repeat
use
onestep
qrtpcr
parallel
xpert
flu
panel
day
detail
inform
qrt
pcr
assay
pathogen
list
tabl
avail
upon
request
determin
analyt
reactiv
clinic
specimen
combin
nose
throat
swab
glucoselactalbuminyeast
viral
transport
medium
gli
contain
differ
influenza
virus
varieti
viral
load
inconsist
qrtpcr
result
sever
influenza
viru
isol
differ
dilut
gli
qualiti
control
molecular
diagnost
qcmd
influenza
viru
haemagglutinin
type
extern
qualiti
assess
eqa
panel
consist
variou
dilut
influenza
viru
isol
viru
transport
medium
use
tabl
determin
analyt
specif
respiratori
panel
neg
specimen
use
tabl
determin
analyt
sensit
qrtpcr
cycl
threshold
ct
valu
use
semiquantit
measur
wherea
determin
exact
viral
load
viru
particl
per
ml
electron
microscopi
em
count
standard
human
influenza
apuerto
use
specimen
parallel
test
xpert
flu
panel
qrtpcr
freezethaw
cycl
univers
transport
medium
utm
copan
italia
spa
itali
prefer
specimen
transport
medium
xpert
flu
panel
use
gli
transport
medium
compar
perform
transport
media
dilut
clinic
specimen
utm
gli
analys
dilut
specimen
assay
tabl
none
specimen
respiratori
panel
contain
virus
influenza
viru
bacteria
commonli
detect
specimen
patient
influenzalik
ill
posit
xpert
flu
panel
test
tabl
addit
four
viru
neg
specimen
also
neg
xpert
flu
panel
test
use
em
count
standard
viral
load
viru
isol
determin
season
sd
viru
particl
per
ml
sd
viru
particl
per
ml
abilthoven
sd
viru
particl
per
ml
qrtpcr
xpert
flu
panel
matrix
test
perform
similar
three
virus
analyt
sensit
viral
particl
per
ml
fig
shown
tabl
specimen
lowest
viral
load
test
given
subtyp
ct
valu
qrtpcr
matrix
assay
greater
preliminari
result
user
xpert
flu
panel
assay
suggest
freezethaw
nose
throat
swab
collect
utm
might
result
clog
cartridg
none
freezethaw
clinic
specimen
gli
analys
studi
notic
reduc
perform
due
clog
cartridg
signific
differ
found
xpert
flu
panel
qrtpcr
three
origin
clinic
specimen
dilut
gli
utm
subsequ
freezethaw
fig
us
food
drug
administr
fda
grant
emerg
use
author
use
cepheid
xpert
flu
panel
grant
decemb
iquum
liat
influenza
assay
grant
may
test
detect
influenza
viru
identif
subtyp
laboratori
certifi
clinic
laboratori
improv
amend
clia
perform
moder
complex
test
enabl
test
perform
hospit
nearpati
aka
poc
set
poc
use
genexpert
system
avail
apparatu
link
laptop
barcod
reader
iquum
system
allinon
system
need
addit
equip
howev
compar
iquum
system
genexpert
system
offer
alreadi
use
rapid
diagnost
eg
methicillinresist
staphylococcu
aureu
enteroviru
cerebrospin
fluid
nevertheless
promis
rapid
diagnosi
respiratori
ill
filmarray
respiratori
panel
combin
sampl
prepar
realtim
rt
pcr
detect
virus
includ
variant
three
bacteria
commonli
found
acut
respiratori
infect
within
one
hour
http
wwwidahotechcomfilmarray
howev
system
current
still
clinic
trial
phase
fda
clearanc
xpert
flu
panel
test
easi
perform
took
one
hour
start
result
less
one
minut
handson
time
result
easi
interpret
clear
positiveneg
inform
eg
clinician
inform
ct
valu
amplif
curv
user
qrtpcr
experi
fig
valid
test
clearli
indic
result
sampl
process
control
probecheck
analyt
evalu
show
potenti
xpert
flu
panel
becom
real
poc
molecular
test
howev
limit
determin
xpert
flu
panel
detect
human
influenza
virus
includ
variant
analyt
sensit
similar
qrtpcr
howev
low
viral
load
specimen
detect
addit
viral
load
limit
particularli
notic
avian
influenza
virus
whilst
detect
import
limit
urgent
need
molecular
poc
test
detect
avian
influenza
virus
xpert
flu
panel
test
found
specif
h
gene
viru
abl
subtyp
viru
contain
specimen
found
posit
matrix
test
xpert
flu
panel
howev
specimen
repeat
inconsist
result
qrtpcr
detect
xpert
flu
panel
sequenc
primer
probe
target
qrtpcr
virus
reveal
mismatch
explain
incon
sistent
result
shown
primer
probe
bind
target
includ
xpert
flu
panel
reveal
cepheid
imposs
determin
whether
lack
perform
specimen
caus
mismatch
primer
andor
probe
drift
influenza
virus
necessit
regular
updat
primer
probe
especi
quick
updat
need
viru
mutat
primer
probe
bind
site
becom
domin
viru
season
emerg
use
authoris
commerci
influenza
molecular
test
might
overcom
problem
howev
even
emerg
develop
valid
might
take
longer
season
last
therefor
molecular
poc
never
fulli
replac
inhous
qrtpcr
detect
identif
influenza
virus
contrast
find
other
could
confirm
clog
problem
due
use
utm
freezethaw
clinic
specimen
histor
specimen
vigor
vortex
arriv
disrupt
larg
particl
mucu
flock
might
play
role
clog
omit
poc
set
although
analyt
sensit
xpert
flu
panel
exce
publish
analyt
sensit
antigen
test
least
purchas
genexpert
machin
cost
per
test
approxim
euro
per
cartridg
still
bottleneck
compar
antigen
test
approxim
euro
per
test
real
poc
use
howev
xpert
flu
panel
welcom
altern
antigen
rapid
test
larg
practic
qrtpcr
laboratori
emerg
diagnost
offoffic
hour
becom
realli
use
poc
test
especi
area
avian
influenza
virus
infect
human
endem
xpert
flu
panel
improv
detect
influenza
virus
determin
relev
subtyp
conclus
xpert
flu
panel
first
commerci
avail
poc
molecular
test
detect
influenza
viru
determin
subtyp
analyt
reason
sensit
compar
qrtpcr
highli
specif
therefor
welcom
altern
antigen
poc
test
none
none
declar
requir
